Invesaro

Stocks Comparison

Progyny vs Viemed Healthcare: revenue, profit, margins and growth compared

Progyny brought in $1.3B of revenue in fiscal 2025, Viemed Healthcare $270.3M in fiscal 2025. Revenue changed by +10.4% at Progyny and +20.5% at Viemed Healthcare on the year before, so Viemed Healthcare grew faster. Progyny kept 4.5% of its revenue as net profit, Viemed Healthcare 5.5%. Free cash flow was $191.8M at Progyny and $11.9M at Viemed Healthcare.

Side by side, latest fiscal year

PGNYVMD
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$1.3B$270.3M
Revenue growth+10.4%+20.5%
Net income$58.5M$14.9M
Net margin4.5%5.5%
Free cash flow$191.8M$11.9M
Free cash flow margin14.9%4.4%
Earnings per share (diluted)$0.65$0.37
Cash$112.2M$13.5M
Debtn/a$12.4M
Price to earnings39.124.1
Market value$2B$339.4M
Dividend yieldn/an/a
Rank by revenue in sector#133 of 523 · Health care#231 of 523 · Health care

Over the years

Revenue
PGNY FY2019: $105.4MPGNY FY2019: $229.7MPGNY FY2020: $344.9MPGNY FY2021: $500.6MPGNY FY2022: $786.9MPGNY FY2023: $1.1BPGNY FY2024: $1.2BPGNY FY2025: $1.3BVMD FY2019: $64.5MVMD FY2019: $80.3MVMD FY2020: $131.3MVMD FY2021: $117.1MVMD FY2022: $138.8MVMD FY2023: $183MVMD FY2024: $224.3MVMD FY2025: $270.3MFY19FY20FY21FY22FY23FY24FY25
PGNY $1.3BVMD $270.3M
Net income
PGNY FY2019: $661KPGNY FY2019: -$8.6MPGNY FY2020: $46.5MPGNY FY2021: $65.8MPGNY FY2022: $30.4MPGNY FY2023: $62MPGNY FY2024: $54.3MPGNY FY2025: $58.5MVMD FY2019: $9.5MVMD FY2019: $8.5MVMD FY2020: $31.5MVMD FY2021: $9.1MVMD FY2022: $6.2MVMD FY2023: $10.2MVMD FY2024: $11.3MVMD FY2025: $14.9MFY19FY20FY21FY22FY23FY24FY25
PGNY $58.5MVMD $14.9M
Net margin
PGNY FY2019: 0.6%PGNY FY2019: -3.7%PGNY FY2020: 13.5%PGNY FY2021: 13.1%PGNY FY2022: 3.9%PGNY FY2023: 5.7%PGNY FY2024: 4.7%PGNY FY2025: 4.5%VMD FY2019: 14.7%VMD FY2019: 10.6%VMD FY2020: 24.0%VMD FY2021: 7.8%VMD FY2022: 4.5%VMD FY2023: 5.6%VMD FY2024: 5.0%VMD FY2025: 5.5%FY19FY20FY21FY22FY23FY24FY25
PGNY 4.5%VMD 5.5%
Revenue growth
PGNY FY2019: +117.9%PGNY FY2020: +50.1%PGNY FY2021: +45.2%PGNY FY2022: +57.2%PGNY FY2023: +38.3%PGNY FY2024: +7.2%PGNY FY2025: +10.4%VMD FY2019: +24.5%VMD FY2020: +63.6%VMD FY2021: -10.8%VMD FY2022: +18.6%VMD FY2023: +31.8%VMD FY2024: +22.5%VMD FY2025: +20.5%FY19FY20FY21FY22FY23FY24FY25
PGNY +10.4%VMD +20.5%
Free cash flow
PGNY FY2019: $1.7MPGNY FY2019: -$4.5MPGNY FY2020: $35.2MPGNY FY2021: $23.9MPGNY FY2022: $77.2MPGNY FY2023: $185.2MPGNY FY2024: $173.7MPGNY FY2025: $191.8MVMD FY2019: $16.3MVMD FY2019: $5.7MVMD FY2020: $22.1MVMD FY2021: $2.8MVMD FY2022: $4.9MVMD FY2023: $19.1MVMD FY2024: $1.3MVMD FY2025: $11.9MFY19FY20FY21FY22FY23FY24FY25
PGNY $191.8MVMD $11.9M

Fiscal years as each company reports them; the two may end in different months.

Questions about Progyny and Viemed Healthcare

Which is bigger by revenue, Progyny or Viemed Healthcare?

Progyny is bigger by revenue: $1.3B in fiscal 2025, against $270.3M for Viemed Healthcare in fiscal 2025.

Which keeps more of its revenue as profit, Progyny or Viemed Healthcare?

Progyny had a net margin of 4.5% in fiscal 2025; Viemed Healthcare had 5.5% in fiscal 2025.

Which grew revenue faster, Progyny or Viemed Healthcare?

In their latest fiscal years revenue changed by +10.4% at Progyny and +20.5% at Viemed Healthcare.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies